Jommi, C., & Ravasio, R. (2019). The value of obinutuzumab for untreated advanced Follicular Lymphoma: an assessment based on Multicriteria Decision Analysis (MCDA). AboutOpen, 6(1), 78–85. https://doi.org/10.33393/abtpn.2019.302